TipRanks
AstraZeneca PLC (MX:AZN1N)
:AZN1N
Mexico Market
AZN1N
AstraZeneca
RESEARCH TOOLSreports

AstraZeneca (AZN1N) Stock News & Sentiment

0 Followers
AstraZeneca’s Kazakhstan Breast Cancer Study: Real‑World Data With Quiet but Important Signals for AZN
Premium
Company Announcements
AstraZeneca’s Kazakhstan Breast Cancer Study: Real‑World Data With Quiet but Important Signals for AZN
1d ago
AZN
AstraZeneca’s Real World COPD Study in Russia Signals Strategic Respiratory Focus
Premium
Company Announcements
AstraZeneca’s Real World COPD Study in Russia Signals Strategic Respiratory Focus
3d ago
AZN
AstraZeneca: Strong Pipeline and Growth Outlook Support Buy Rating and Unchanged 16,500 GBp Price Target
Premium
Ratings
AstraZeneca: Strong Pipeline and Growth Outlook Support Buy Rating and Unchanged 16,500 GBp Price Target
4d ago
AZN
AstraZeneca invests $2bn in Summit to accelerate bispecific and ADC cancer portfolio
Premium
Company Announcements
AstraZeneca invests $2bn in Summit to accelerate bispecific and ADC cancer portfolio
4d ago
AZN
AstraZeneca, Daiichi Sankyo and Summit expand ADC–immunotherapy push with Datroway–ivonescimab trials
Premium
Company Announcements
AstraZeneca, Daiichi Sankyo and Summit expand ADC–immunotherapy push with Datroway–ivonescimab trials
8d ago
AZN
AstraZeneca Adds Employee Scheme Shares to London Listing
Premium
Company Announcements
AstraZeneca Adds Employee Scheme Shares to London Listing
8d ago
AZN
AstraZeneca Confirms Total Voting Rights and Share Capital Structure
Premium
Company Announcements
AstraZeneca Confirms Total Voting Rights and Share Capital Structure
8d ago
AZN
More MX:AZN1N News >

AZN1N News on the Web

AstraZeneca Opens New $1 Bln R&D Hub To Strengthen Global Drug Research
rttnews
Bullish
Barclays Sticks to Their Buy Rating for AstraZeneca (AZN)
TipRanks News
Bullish
AstraZeneca Stocks Moves Lower as Datroway Combination Enters Phase 3
GuruFocus News
Bearish
Big Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals
CNBC
Bullish
Summit Therapeutics enters trial collaboration with AstraZeneca, Daiichi Sankyo
TipRanks News
Neutral
Daiichi Sankyo, AstraZenca, Summit Partner To Evaluate Datroway Plus Ivonescimab
rttnews
Neutral
AstraZeneca Secures $2 Billion Summit Therapeutics Oncology Partnership, Bolstering GI Cancer Pipeline and Supporting Buy Rating on AZN
TipRanks News
Bullish
Astrazeneca (AZN) Registers a Bigger Fall Than the Market: Important Facts to Note
Zacks
Neutral

News Score - Last 7 Days

Positive
MX:AZN1N
Sector Average
Media Buzz
This Week32 articles
Weekly Average41.75 articles
News Sentiment
This Week94%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MX:AZN1N’s Media Buzz Sentiment?
32 articles about MX:AZN1N were published this week. In an average week, 41.75 articles are published.
    What is MX:AZN1N’s weekly average amount of articles?
    In an average week, 41.75 articles about MX:AZN1N are published.
      What is MX:AZN1N’s News Sentiment?
      94% of articles about MX:AZN1N were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        AMGNAmgen
        MCKMcKesson
        ONCBeOne Medicines
        NVSNovartis
        NTRANatera
        Showing the stocks with the most bullish news sentiment over the past week